cyclopentane has been researched along with Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Fujimoto, S; Imai, G; Imai, H; Matsuzono, K | 1 |
| HABERMANN, H | 1 |
| Froestl, W; Kusek, M; Pilc, A; Tokarski, K; Wabno, J; WieroĊska, JM | 1 |
| Dagaev, SG; Dolgo-Saburov, VB; Fil'ko, OA; Glukhova, RI; Khrabrova, AV; Kubarskaya, LG; Mukovskii, LA; Sanotskii, VI | 1 |
4 other study(ies) available for cyclopentane and Syndrome
| Article | Year |
|---|---|
Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson's disease with improvement after intravenous peramivir treatment.
Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Antiparkinson Agents; Antiviral Agents; Cyclopentanes; Disease Progression; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Parkinson Disease; Syndrome | 2019 |
Experience with the new preparation Parpanit in the treatment of diseases of the extrapyramidal motor system.
Topics: Basal Ganglia Diseases; Cyclopentanes; Syndrome | 1948 |
The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.
Topics: Animals; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Frontal Lobe; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Hyperkinesis; Male; Mice; Motor Activity; Phosphinic Acids; Psychoses, Substance-Induced; Pyrimidines; Receptors, GABA-B; Syndrome | 2011 |
Effect of M2 muscarinic receptor blockade in rats with haloperidol-produced catatonic syndrome.
Topics: Animals; Catalepsy; Cyclopentanes; Diamines; Dopamine; Haloperidol; Male; Mandelic Acids; Muscarinic Antagonists; Piperidines; Receptor, Muscarinic M2; Syndrome; Trihexyphenidyl | 2004 |